|
MRK
|
Healthcare |
BMO Capital |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$286.5B
|
$99.52
|
-0.7%
|
-1.5%
|
+1.3%
|
+0.1%
|
+0.4%
|
-0.2%
|
|
NKE
|
Consumer Cyclical |
Telsey Advisory Group |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$63.1B
|
$77.10
|
-1.5%
|
-0.2%
|
-0.2%
|
+0.0%
|
+0.2%
|
-0.7%
|
|
BIIB
|
Healthcare |
BMO Capital |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$27.6B
|
$147.39
|
-1.2%
|
-0.6%
|
+2.0%
|
-0.2%
|
+0.6%
|
+0.9%
|
|
LEN
|
Consumer Cyclical |
BTIG |
Downgrade
|
Buy
→
Neutral
|
—
|
$21.4B
|
$138.40
|
-0.4%
|
-0.2%
|
-0.1%
|
+0.0%
|
+0.5%
|
-1.0%
|
|
KIM
|
Real Estate |
JP Morgan |
Downgrade
|
Overweight
→
Neutral
|
—
|
$15.7B
|
$23.01
|
+0.1%
|
+1.8%
|
+0.0%
|
+0.8%
|
-0.0%
|
-1.0%
|
|
EXEL
|
Healthcare |
BMO Capital |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$13.7B
|
$33.68
|
-1.1%
|
-1.2%
|
+0.6%
|
+1.0%
|
+0.6%
|
-0.6%
|
|
LINE
|
Real Estate |
JP Morgan |
Downgrade
|
Overweight
→
Neutral
|
—
|
$8.7B
|
$56.90
|
+0.2%
|
+2.9%
|
-0.1%
|
+0.0%
|
+0.5%
|
+0.2%
|
|
HR
|
Real Estate |
JP Morgan |
Downgrade
|
Overweight
→
Neutral
|
—
|
$7.1B
|
$16.70
|
+0.4%
|
+1.1%
|
+0.1%
|
+0.8%
|
+0.0%
|
-0.9%
|
|
LW
|
Consumer Defensive |
Citigroup |
Downgrade
|
Buy
→
Neutral
|
—
|
$6.0B
|
$62.50
|
-0.1%
|
-0.7%
|
+2.9%
|
-0.3%
|
+2.5%
|
+2.6%
|
|
PBF
|
Energy |
TD Cowen |
Downgrade
|
Hold
→
Sell
|
—
|
$4.9B
|
$25.46
|
-3.1%
|
-1.2%
|
+1.0%
|
+1.0%
|
+0.2%
|
-1.2%
|
|
LAZ
|
Financial Services |
Keefe, Bruyette & Woods |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$4.8B
|
$50.49
|
-1.0%
|
+3.1%
|
+0.4%
|
-0.7%
|
+0.2%
|
-0.1%
|
|
IIPR
|
Real Estate |
Compass Point |
Downgrade
|
Buy
→
Neutral
|
—
|
$1.5B
|
$95.34
|
-22.4%
|
-22.7%
|
-4.4%
|
-0.1%
|
+0.5%
|
-3.7%
|
|
CABA
|
Healthcare |
Evercore ISI |
Downgrade
|
Outperform
→
In Line
|
—
|
$352M
|
$2.31
|
-1.7%
|
+3.0%
|
-0.8%
|
-0.8%
|
+6.4%
|
-8.0%
|
|
RXST
|
Healthcare |
Stifel |
Downgrade
|
Buy
→
Hold
|
—
|
$245M
|
$38.19
|
-7.3%
|
-11.9%
|
+2.8%
|
-0.3%
|
+1.7%
|
-2.4%
|
|
SPRO
|
Healthcare |
Evercore ISI |
Downgrade
|
Outperform
→
In Line
|
—
|
$152M
|
$1.00
|
-0.8%
|
-4.3%
|
-3.4%
|
+1.6%
|
+0.7%
|
+9.1%
|